Betahistine in the treatment of tinnitus in patients with vestibular disorders
dc.contributor.author | Ganança, Mauricio Malavasi [UNIFESP] | |
dc.contributor.author | Caovilla, Heloisa Helena [UNIFESP] | |
dc.contributor.author | Gazzola, Juliana Maria | |
dc.contributor.author | Gananca, Cristina Freitas [UNIFESP] | |
dc.contributor.author | Ganança, Fernando Freitas [UNIFESP] | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Univ Bandeirante Sao Paulo | |
dc.date.accessioned | 2018-06-15T16:24:05Z | |
dc.date.available | 2018-06-15T16:24:05Z | |
dc.date.issued | 2011-07-01 | |
dc.description.abstract | Betahistine is a medicine used to treat vestibular disorders that has also been used to treat tinnitus.Aim: To assess the effects of betahistine on tinnitus in patients with vestibular disorders.Material and method: Retrospective data were collected from patient records for individuals presenting with vestibular dysfunction and tinnitus. Patients included had received betahistine 48 mg/day and clinical outcomes were compared with a control group comprising individuals who were unable to receive betahistine due to gastritis, ulcers, pregnancy, asthma or hypersensitivity to the drug. Patients underwent control of any aggravating factors and also standard vestibular exercises as a basis for treatment. The intensity, frequency and duration of tinnitus were assessed on the first day of dosing and after 120 days of treatment. Clinical improvement was defined as a total or partial reduction of tinnitus after treatment.Results: Clinical improvement was observed in 80/262 (30.5%) of patients treated with betahistine and 43/252 (17.1%) of control patients. Betahistine significantly (p<0.0001) improved tinnitus in treated individuals.Conclusion: The daily dosage of 48 mg of betahistine during 120 consecutive days is useful to reduce or eliminate tinnitus in patients with vestibular disorders. | en |
dc.description.affiliation | Fed Univ Sao Paulo UNIFESP, Paulista Sch Med EPM, Sao Paulo, Brazil | |
dc.description.affiliation | Univ Bandeirante Sao Paulo, Program Body Balance Rehabil & Social Inclus, Sao Paulo, Brazil | |
dc.description.affiliation | Univ Fed Sao Paulo, Otol & Neurotol Program, Paulista Sch Med, Sao Paulo, Brazil | |
dc.description.affiliation | Univ Fed Sao Paulo, Dept Speech & Hearing Therapy, Paulista Sch Med, Human Commun Disorders Grad Program, Sao Paulo, Brazil | |
dc.description.affiliation | Univ Fed Sao Paulo, Otol & Neurotol Program, UNIFESP EPM, Sao Paulo, Brazil | |
dc.description.affiliationUnifesp | Fed Univ Sao Paulo UNIFESP, Paulista Sch Med EPM, Sao Paulo, Brazil | |
dc.description.affiliationUnifesp | Univ Fed Sao Paulo, Otol & Neurotol Program, Paulista Sch Med, Sao Paulo, Brazil | |
dc.description.affiliationUnifesp | Univ Fed Sao Paulo, Dept Speech & Hearing Therapy, Paulista Sch Med, Human Commun Disorders Grad Program, Sao Paulo, Brazil | |
dc.description.affiliationUnifesp | Univ Fed Sao Paulo, Otol & Neurotol Program, UNIFESP EPM, Sao Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.format.extent | 499-503 | |
dc.identifier | http://dx.doi.org/10.1590/S1808-86942011000400014 | |
dc.identifier.citation | Brazilian Journal Of Otorhinolaryngology. Sao Paulo: Assoc Brasileira Otorrinolaringologia & Cirurgia Cervicofacial, v. 77, n. 4, p. 499-503, 2011. | |
dc.identifier.doi | 10.1590/S1808-86942011000400014 | |
dc.identifier.file | S1808-86942011000400014-en.pdf | |
dc.identifier.file | S1808-86942011000400014-pt.pdf | |
dc.identifier.issn | 1808-8694 | |
dc.identifier.scielo | S1808-86942011000400014 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/43153 | |
dc.identifier.wos | WOS:000293863600014 | |
dc.language.iso | eng | |
dc.publisher | Assoc Brasileira Otorrinolaringologia & Cirurgia Cervicofacial | |
dc.relation.ispartof | Brazilian Journal Of Otorhinolaryngology | |
dc.rights | Acesso aberto | |
dc.subject | dizziness | en |
dc.subject | medication therapy | en |
dc.subject | management | en |
dc.subject | tinnitus | en |
dc.subject | vertigo | en |
dc.title | Betahistine in the treatment of tinnitus in patients with vestibular disorders | en |
dc.title.alternative | Betaistina no tratamento do zumbido em pacientes com distúrbios vestibulares | pt |
dc.type | Artigo |